vimarsana.com
Home
Live Updates
Outlook Therapeutics® Reports Financial Results for Fis
Outlook Therapeutics® Reports Financial Results for Fis
Outlook Therapeutics® Reports Financial Results for Fiscal
Commencement of ONS-5010 NORSE EIGHT clinical trial targeted for first calendar quarter of 2024Company reaffirms potential for European approval for...
Related Keywords
Japan ,
United States ,
China ,
United Kingdom ,
Russell Trenary ,
Jenene Thomas ,
Outlook Therapeutics Inc ,
European Medicines Agency ,
Exchange Commission ,
Nasdaq ,
Amerisourcebergen ,
Drug Administration ,
Committee For Medicinal Products Human Use ,
Marketing Authorization Application ,
License Application ,
Chief Executive Officer ,
Protocol Assessment ,
Regulatory Update ,
Outlook Therapeutics ,
Medicinal Products ,
Human Use ,
Syntone Biopharma ,
Year Ended September ,
Outlook Therapeutic ,
Annual Report ,
Nasdaq Otlk ,
Nc ,